This segment focuses on the research, development, and commercialization of hyaluronic acid-based dermal fillers and other injectables for facial rejuvenation and aesthetic enhancement. Imeik's R&D efforts are directed towards improving the safety, efficacy, and longevity of its filler products. The company employs advanced cross-linking technologies and biocompatible materials to create fillers with optimal viscoelastic properties and minimal adverse effects. Clinical trials are conducted to evaluate the performance of new formulations and indications. The segment addresses the growing demand for non-surgical cosmetic procedures and aims to provide patients with natural-looking and long-lasting results. Imeik's market positioning is strengthened by its strong brand recognition and distribution network in China.

This segment encompasses the development and marketing of a range of skincare products, including moisturizing lotions, anti-wrinkle serums, essence creams, and hydrating masks. Imeik's R&D activities in this area focus on incorporating innovative ingredients and delivery systems to enhance the efficacy of its skincare formulations. The company utilizes advanced technologies such as chitosan and kinetic energy to improve skin hydration, firmness, and radiance. Clinical studies are conducted to assess the safety and effectiveness of new products. The segment targets consumers seeking high-quality skincare solutions with proven results. Imeik's competitive advantage lies in its ability to leverage its expertise in biomedical materials and aesthetics to create differentiated skincare products with strong scientific backing.